These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 30568391)
21. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer. Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255 [TBL] [Abstract][Full Text] [Related]
22. Utilization of interventional radiology in the postoperative management of patients after surgery for locally advanced and recurrent rectal cancer. Llaguna OH; Calvo BF; Stitzenberg KB; Deal AM; Burke CT; Dixon RG; Stavas JM; Meyers MO Am Surg; 2011 Aug; 77(8):1086-90. PubMed ID: 21944529 [TBL] [Abstract][Full Text] [Related]
23. [Microsurgical reconstruction of the pelvic floor after pelvic exenteration. Reduced morbidity and improved quality of life by an interdisciplinary concept]. Stechl NM; Baumeister S; Grimm K; Kraus TW; Bockhorn H; Exner KE Chirurg; 2011 Jul; 82(7):625-30. PubMed ID: 21161142 [TBL] [Abstract][Full Text] [Related]
24. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes. Kazi M; Kumar NAN; Rohila J; Sukumar V; Engineer R; Ankathi S; Desouza A; Saklani A BJS Open; 2021 Sep; 5(5):. PubMed ID: 34518872 [TBL] [Abstract][Full Text] [Related]
25. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers. Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831 [TBL] [Abstract][Full Text] [Related]
27. Excision of the seminal vesicles for locally advanced and recurrent rectal and sigmoid cancer. Keating JP; Manning S; Dennett E; Studd R ANZ J Surg; 2017 Sep; 87(9):688-691. PubMed ID: 25827193 [TBL] [Abstract][Full Text] [Related]
28. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925 [TBL] [Abstract][Full Text] [Related]
29. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer]. Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427 [No Abstract] [Full Text] [Related]
30. NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial). Brouquet A; Bachet JB; Huguet F; Karoui M; Artru P; Sabbagh C; Lefèvre JH; Vernerey D; Mariette C; Vicaut E; Benoist S; BMC Cancer; 2020 May; 20(1):485. PubMed ID: 32471382 [TBL] [Abstract][Full Text] [Related]
32. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy. Williams M; Perera M; Nouhaud FX; Coughlin G Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928 [TBL] [Abstract][Full Text] [Related]
33. Outcomes of extended total mesorectal excision in patients with locally advanced rectal cancer. Saravanabavan S; Kazi M; Murugan J; Vispute T; Vijayakumaran P; Desouza A; Saklani A Colorectal Dis; 2023 Jul; 25(7):1423-1432. PubMed ID: 37246309 [TBL] [Abstract][Full Text] [Related]
34. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome. Bogner A; Fritzmann J; Müssle B; Huber J; Dobroschke J; Bork U; Wolk S; Distler M; Weitz J; Welsch T; Kahlert C Int J Colorectal Dis; 2021 Aug; 36(8):1701-1710. PubMed ID: 33677655 [TBL] [Abstract][Full Text] [Related]
35. Determinants of survival following pelvic exenteration for primary rectal cancer. Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J; Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525 [TBL] [Abstract][Full Text] [Related]
36. The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer. Harris CA; Solomon MJ; Heriot AG; Sagar PM; Tekkis PP; Dixon L; Pascoe R; Dobbs BR; Frampton CM; Harji DP; Kontovounisios C; Austin KK; Koh CE; Lee PJ; Lynch AC; Warrier SK; Frizelle FA Ann Surg; 2016 Aug; 264(2):323-9. PubMed ID: 26692078 [TBL] [Abstract][Full Text] [Related]
37. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience. Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855 [TBL] [Abstract][Full Text] [Related]
38. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes? Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945 [TBL] [Abstract][Full Text] [Related]
39. Laparoscopic versus open surgery for stage I rectal cancer: long-term oncologic outcomes. Lee SD; Park SC; Park JW; Kim DY; Choi HS; Oh JH World J Surg; 2013 Mar; 37(3):646-51. PubMed ID: 23188532 [TBL] [Abstract][Full Text] [Related]